Rudy Li

Stock Analyst at Chardan Capital

(2.23)
# 1139
Out of 5,441 analysts
24
Total ratings
Success rate
Average return
Main Sectors:
Top Industries:
7 Stocks
Name Action PT Current % Upside Ratings Updated
STOK Stoke Therapeutics
Maintains: Buy
24 24
13.14 82.65% 4 Aug 13, 2025
XENE Xenon Pharmaceutical...
Maintains: Buy
55 55
34.12 61.2% 3 Aug 12, 2025
CNTA Centessa Pharmaceuti...
Maintains: Buy
30 30
16.6 80.72% 3 Aug 12, 2025
PRTA Prothena Corp
Maintains: Buy
18 18
7.67 134.68% 6 Aug 5, 2025
MNMD Mind Medicine
Maintains: Buy
20 20
9.98 100.4% 4 Aug 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
80 80
44.96 77.94% 2 Jul 29, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
80 80
38.56 107.47% 2 May 21, 2025